PMID- 30774324 OWN - NLM STAT- MEDLINE DCOM- 20190729 LR - 20231005 IS - 1178-2005 (Electronic) IS - 1176-9106 (Print) IS - 1176-9106 (Linking) VI - 14 DP - 2019 TI - Minimal clinically important difference of 3-minute chair rise test and the DIRECT questionnaire after pulmonary rehabilitation in COPD patients. PG - 261-269 LID - 10.2147/COPD.S187567 [doi] AB - BACKGROUND: The 3-minute chair rise test (3-minute CRT) and the Disability Related to COPD Tool (DIRECT) are two reproducible and valid short tests that can assess the benefit of pulmonary rehabilitation (PR) in terms of functional capacity and dyspnea in everyday activities. METHODS: We determined the minimal clinically important difference (MCID) of the DIRECT questionnaire and 3-minute CRT using distribution methods and anchor encroaches with a panel of eight standard tests in a cohort of 116 COPD patients who completed a PR program in real-life settings. RESULTS: The estimated MCID for the 3-minute CRT and DIRECT scores was five repetitions and two units, respectively, using separate and combined independent anchors. The all-patient (body mass index-obstruction-dyspnea-exercise [BODE] scores 0-7), BODE 0-2 (n=42), and BODE 3-4 (n=50) groups showed improvements greater than the MCID in most tests and questionnaires used. In contrast, the BODE 5-7 group (n=24) showed improvements greater than MCID in only the 3-minute CRT, 6-minute walk test, endurance exercise test, and DIRECT questionnaire. DISCUSSION AND CONCLUSION: This study demonstrates that the short and simple DIRECT questionnaire and 3-minute CRT are responsive to capture the beneficial effects of a PR program in COPD patients, including those with severe disease. TRIAL REGISTRATION NUMBER: NCT03286660. FAU - Levesque, Jonathan AU - Levesque J AD - Department of Medicine, Pneumology Service, Hopital Maisonneuve-Rosemont, Faculty of Medicine, Universite de Montreal, Montreal, Quebec, Canada. FAU - Antoniadis, Anestis AU - Antoniadis A AD - Laboratoire Jean Kuntzmann UMR5224, Statistics Department, Universite Grenoble-Alpes, Grenoble, France. FAU - Li, Pei Zhi AU - Li PZ AD - Montreal Chest Institute, McGill University Health Center Research Institute, McGill University, Montreal, Quebec, Canada. FAU - Herengt, Frederic AU - Herengt F AD - Centre de Readaptation Cardio-Respiratoire-Dieulefit Sante, Dieulefit, France. FAU - Brosson, Christophe AU - Brosson C AD - Private Physiotherapist, Cours Liberation, Grenoble, France. FAU - Grosbois, Jean-Marie AU - Grosbois JM AD - Pneumology Service, Centre Hospitalier de Bethune, Bethune, France. FAU - Bernady, Alain AU - Bernady A AD - Toki-Eder Centre Medical Cardio-Respiratoire, Cambo-les-Bains, France. FAU - Bender, Anthony AU - Bender A AD - Private Physiotherapist, Boulevard de Metz Mont-Saint-Martin, France. AD - LUNEX International University of Health, Exercise and Sports, Differdange, Luxembourg. FAU - Favre, Murielle AU - Favre M AD - Centre de Pneumologie Henri Bazire, Saint-Julien-de-Ratz, France. FAU - Guerder, Antoine AU - Guerder A AD - AP-HP, Groupe Hospitalier Pitie-Salpetriere Charles Foix, Service de Pneumologie, Medecine Intensive et Reanimation, Departement R3S, Paris, France. FAU - Surpas, Pascale AU - Surpas P AD - Centre Medical de Bayere, Charnay, France. FAU - Similowski, Thomas AU - Similowski T AD - AP-HP, Groupe Hospitalier Pitie-Salpetriere Charles Foix, Service de Pneumologie, Medecine Intensive et Reanimation, Departement R3S, Paris, France. AD - Sorbonne Universite, INSERM, UMRS1158 Neurophysiologie Respiratoire Experimentale et Clinique, Paris, France. FAU - Aguilaniu, Bernard AU - Aguilaniu B AD - Faculty of Medicine, Universite Grenoble-Alpes, Grenoble, France, b.aguilaniu@icloud.com. LA - eng SI - ClinicalTrials.gov/NCT03286660 PT - Comparative Study PT - Journal Article PT - Multicenter Study PT - Observational Study DEP - 20190122 PL - New Zealand TA - Int J Chron Obstruct Pulmon Dis JT - International journal of chronic obstructive pulmonary disease JID - 101273481 MH - Activities of Daily Living MH - Aged MH - *Disability Evaluation MH - Europe MH - *Exercise Test MH - Exercise Tolerance MH - Female MH - Health Status MH - Humans MH - Lung/*physiopathology MH - Male MH - Middle Aged MH - *Minimal Clinically Important Difference MH - Predictive Value of Tests MH - Prospective Studies MH - Pulmonary Disease, Chronic Obstructive/*diagnosis/physiopathology/*rehabilitation MH - Quebec MH - Recovery of Function MH - Severity of Illness Index MH - *Surveys and Questionnaires MH - Time Factors MH - Treatment Outcome MH - Walk Test PMC - PMC6349077 OTO - NOTNLM OT - COPD OT - MCID OT - chair tests OT - outcomes assessment OT - pulmonary rehabilitation OT - tools COIS- Disclosure Financial support for this study was provided by an unrestricted grant from Boehringer Ingelheim, France. BA reports grants and other from Boehringer Ingelheim, France, during the conduct of the study. The authors report no other conflicts of interest in this work. EDAT- 2019/02/19 06:00 MHDA- 2019/07/30 06:00 PMCR- 2019/01/22 CRDT- 2019/02/19 06:00 PHST- 2019/02/19 06:00 [entrez] PHST- 2019/02/19 06:00 [pubmed] PHST- 2019/07/30 06:00 [medline] PHST- 2019/01/22 00:00 [pmc-release] AID - copd-14-261 [pii] AID - 10.2147/COPD.S187567 [doi] PST - epublish SO - Int J Chron Obstruct Pulmon Dis. 2019 Jan 22;14:261-269. doi: 10.2147/COPD.S187567. eCollection 2019.